A New Approach to Autoimmune Disease Treatment Takes a Big Step Forward

Share:

Benaroya Research Institute researchers, including Ritika Tewari, PhD, and Soo Jung Yang, PhD, are investigating new treatment approaches for primary biliary cholangitis, a rare autoimmune disease that can lead to liver failure. Even after a liver transplant, the disease may recur as immune cells attack the new liver. Their research focuses on reprogramming T cells to become regulatory T cells, which help prevent autoimmune reactions.